关于我们
September 30, 2014 - Gallus BioPharmaceuticals, LLC has been acquired by DPx Holdings B.V., privately owned by JLL Partners and Royal DSM and the parent company of Patheon. Patheon’s biologic drug substance business, a unit of DPx Holdings, now spans four global facilities in Europe, Australia and North America and includes more than 550 employees. Please visit the Patheon LinkedIn page to learn more about our expanded capabilities and to follow Patheon. Visit our website at www.Patheon.com
- 网站
-
https://www.Patheon.com
Laureate Biopharmaceutical Services的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- St. Louis，Missouri
- 类型
- 私人持股
- 创立
- 2011
- 领域
- Cell Line Optimization、Upstream & Downstream Process Development、Drug Substance Manufacturing、Bioreactor Production from 20 to 2,000L、Purification at Scale、Protein Modification and Conjugation、Formulation and Aseptic Filling、cGMP和Single-Use Technologies